The US Food and Drug Administration has granted 510(k) clearance for Unisense FertiliTech’s Compare & Select feature in the EmbryoViewer software, an accessory in the EmbryoScope time-lapse incubator.
The company said that evaluation criteria already implemented for embryo selection in a specific clinic can be converted into a model in the Compare & Select feature of the EmbryoViewer software.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The EmbryoScope time-lapse incubator assists IVF professionals in selecting embryos for transfer when treating infertile couples or individuals who want to be a parent.
Unisense FertiliTech chief commercial officer Vagn Rasmussen said: "We’re excited to receive the FDA 510(k) clearance for the EmbryoViewer software, and believe this will aid IVF professionals in the selection of embryos that are likely to produce a live birth.
"We have developed a software that allows IVF professionals to observe embryo development events which they may have previously missed.
"The newly released software provides embryologists a new tool to design a set of models that can be used for scoring embryos and provide a stronger and more informed basis to make a better decision."
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe company has obtained FDA 510(k) and CE Mark approvals for the time-lapse system as a Class II medical device. It can be employed for clinical use in ART procedures.
A recent study has showed improvement in clinical outcomes when using a customised embryo evaluation model, which was developed and implemented using the Compare & Select feature of the EmbryoViewer software.
Image: EmbryoScope time-lapse system. Photo: courtesy of PR Newswire/ Unisense FertiliTech A/S.
